Meilong C. Shi
168 Changhai Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].
Journal: Cancer letters
Published: February 06, 2026
T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 30, 2025
Transcriptomic landscape of transposable elements reveals LTR7-PLAAT4 as a potential oncogene and therapeutic target in pancreatic adenocarcinoma.
Journal: Genome research
Published: February 09, 2025
NeoAtlas-Tumor and NeoBert: A Database and A Predictive Model for Canonical and Noncanonical Tumor Neoantigens.
Journal: Genomics, proteomics & bioinformatics
Published: October 01, 2024
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma.
Journal: Translational oncology
Published: September 10, 2024
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.
Journal: Nature communications
Published: January 21, 2024
Erratum: Author Correction: "Dysfunctions" induced by Roux-en-Y gastric bypass surgery are concomitant with metabolic improvement independent of weight loss.
Journal: Cell discovery
Published: May 01, 2020
"Dysfunctions" induced by Roux-en-Y gastric bypass surgery are concomitant with metabolic improvement independent of weight loss.
Journal: Cell discovery
Published: June 03, 2019
Last Updated: 09/26/2026